X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54721) 54721
Book Review (15035) 15035
Publication (3769) 3769
Newspaper Article (243) 243
Book Chapter (186) 186
Magazine Article (183) 183
Conference Proceeding (96) 96
Book / eBook (45) 45
Newsletter (29) 29
Reference (25) 25
Government Document (17) 17
Trade Publication Article (16) 16
Dissertation (13) 13
Web Resource (13) 13
Data Set (2) 2
Presentation (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (48895) 48895
humans (47537) 47537
female (25756) 25756
male (25316) 25316
placebo-controlled trial (20049) 20049
adult (19636) 19636
placebos (18881) 18881
middle aged (17335) 17335
double-blind (17025) 17025
double-blind method (13999) 13999
treatment outcome (11599) 11599
aged (10915) 10915
placebo (10823) 10823
abridged index medicus (8740) 8740
pharmacology & pharmacy (8020) 8020
adolescent (6870) 6870
clinical trials as topic (6088) 6088
psychiatry (6050) 6050
clinical trials (6043) 6043
drug therapy (5684) 5684
care and treatment (5565) 5565
efficacy (5520) 5520
animals (5197) 5197
clinical neurology (4870) 4870
time factors (4746) 4746
research (4636) 4636
medicine, general & internal (4354) 4354
neurosciences (4239) 4239
dose-response relationship, drug (3939) 3939
randomized controlled trials as topic (3856) 3856
administration, oral (3827) 3827
child (3785) 3785
analysis (3780) 3780
randomized controlled-trial (3759) 3759
health aspects (3623) 3623
placebo effect (3414) 3414
young adult (3321) 3321
therapy (3280) 3280
safety (3268) 3268
risk factors (3262) 3262
drug administration schedule (3260) 3260
drug therapy, combination (3250) 3250
medicine & public health (3199) 3199
dosage and administration (3031) 3031
immunology (2960) 2960
prospective studies (2811) 2811
pain (2739) 2739
prevention (2728) 2728
follow-up studies (2605) 2605
aged, 80 and over (2546) 2546
children (2511) 2511
oncology (2417) 2417
internal medicine (2262) 2262
endocrinology & metabolism (2258) 2258
studies (2258) 2258
quality-of-life (2157) 2157
severity of illness index (2086) 2086
gastroenterology & hepatology (2043) 2043
cross-over studies (2040) 2040
medical research (2021) 2021
quality of life (2013) 2013
usage (1978) 1978
surgery (1941) 1941
pediatrics (1907) 1907
article (1899) 1899
child, preschool (1861) 1861
patients (1827) 1827
medicine, research & experimental (1811) 1811
trial (1789) 1789
management (1784) 1784
pharmacotherapy (1734) 1734
infectious diseases (1687) 1687
medicine (1623) 1623
pregnancy (1614) 1614
cancer (1594) 1594
dietary supplements (1586) 1586
mortality (1562) 1562
rheumatology (1544) 1544
disease (1535) 1535
risk (1523) 1523
depression (1508) 1508
cardiac & cardiovascular systems (1470) 1470
antidepressants (1464) 1464
infant (1438) 1438
multicenter (1431) 1431
physiological aspects (1429) 1429
drugs (1402) 1402
metaanalysis (1398) 1398
pharmacology (1390) 1390
obstetrics & gynecology (1382) 1382
pain measurement (1379) 1379
diagnosis (1376) 1376
anesthesiology (1367) 1367
neurology (1359) 1359
chronic disease (1358) 1358
psychiatric status rating scales (1357) 1357
blood pressure - drug effects (1350) 1350
nutrition & dietetics (1343) 1343
review (1335) 1335
pharmacokinetics (1300) 1300
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (33) 33
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
UofT at Mississauga - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Law (Bora Laskin) - Stacks (3) 3
Regis College - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Online Resources - Online (2) 2
St. Augustine's Seminary - Stacks (2) 2
Trinity College (John W Graham) - Wycliffe Storage (2) 2
UofT at Scarborough - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Missing (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (53406) 53406
German (776) 776
French (394) 394
Russian (207) 207
Spanish (172) 172
Italian (115) 115
Danish (53) 53
Polish (52) 52
Japanese (43) 43
Portuguese (36) 36
Swedish (31) 31
Hungarian (18) 18
Norwegian (18) 18
Czech (14) 14
Turkish (10) 10
Dutch (9) 9
Hebrew (6) 6
Korean (6) 6
Bulgarian (5) 5
Lithuanian (5) 5
Chinese (4) 4
Slovak (3) 3
Croatian (2) 2
Finnish (2) 2
Arabic (1) 1
Icelandic (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alcoholism: Clinical and Experimental Research, ISSN 0145-6008, 02/2018, Volume 42, Issue 2, pp. 453 - 460
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 2, pp. 109 - 122
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2159 - 2167
OBJECTIVE To compare the efficacy and safety of dulaglutide, a once-weekly GLP-1 receptor agonist, with placebo and exenatide in type 2 diabetic patients. The... 
GLYCEMIC CONTROL | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | SITAGLIPTIN | ENDOCRINOLOGY & METABOLISM | ANALOG LIRAGLUTIDE | OPEN-LABEL | LY2189265 | TREATED PATIENTS | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Male | Immunoglobulin Fc Fragments - administration & dosage | Thiazolidinediones - administration & dosage | Metformin - adverse effects | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Female | Metformin - administration & dosage | Drug Therapy, Combination | Glucagon-Like Peptides - analogs & derivatives | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Drug Administration Schedule | Venoms - adverse effects | Hypoglycemia - drug therapy | Thiazolidinediones - adverse effects | Blood Glucose - drug effects | Glucagon-Like Peptides - adverse effects | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Care and treatment | Safety and security measures | Dosage and administration | Metformin | Comparative analysis | Exenatide | Clinical trials | Hemoglobin | Diabetes | Product safety | Drug dosages | Placebo effect | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis | Clinical trials | Antiretroviral drugs | Meningitis | Human immunodeficiency virus--HIV | Risk assessment | Medical treatment | Index Medicus
Journal Article
Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1168 - 1174
The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of... 
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | VAGINAL GEL | INDIVIDUALS | SOUTH-AFRICA | PROPHYLAXIS | IN-VITRO | TRANSMISSION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | MALE CIRCUMCISION | RANDOMIZED CONTROLLED-TRIAL | CHALLENGES | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article